Zobrazeno 1 - 10
of 38
pro vyhledávání: '"C.W. Fleming"'
Autor:
Martin C. Tom, Elizabeth Obi, Ahmad Masroor Karimi, Sheen Cherian, Eva Suarez, Chirag Shah, Bindu V. Manyam, C.W. Fleming, Mihir Naik, Rahul D. Tendulkar
Publikováno v:
Journal of Radiation Oncology. 8:305-310
Data from Darby et al. demonstrated that cardiac dose in patients undergoing breast radiation therapy is associated with cardiac events. Cardiac dose is primarily dependent on treatment laterality and treatment fields. More recently, techniques such
Publikováno v:
Essentials of Clinical Radiation Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43e087efa6c553c914761313d9ec5bf6
https://doi.org/10.1891/9780826169099.0024
https://doi.org/10.1891/9780826169099.0024
Publikováno v:
Essentials of Clinical Radiation Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b384d91936566016f0914b4157fd774
https://doi.org/10.1891/9780826169099.0053
https://doi.org/10.1891/9780826169099.0053
Autor:
Robert R. Lorenz, Joycelin F. Canavan, L. Schwartzman, Timothy D. Smile, Chaim Domb, Shauna R. Campbell, Shlomo A. Koyfman, Brandon Prendes, Eric Lamarre, John F. Greskovich, Nikhil Joshi, Lamie A. Ku, Chandana A. Reddy, Brian B. Burkey, Jessica L. Geiger, Deborah J. Chute, Neil M. Woody, Joseph Scharpf, C.W. Fleming
Publikováno v:
Anticancer research. 41(10)
BACKGROUND/AIM Head and neck cancers are often treated with extended courses of radiotherapy (RT), which may prove excessively toxic for frail patients. Split course RT (SCRT) delivers two courses of RT separated by 4-6 weeks, personalizing treatment
Autor:
L. Schwartzman, Shauna R. Campbell, Hong Li, Joycelin F. Canavan, Shlomo A. Koyfman, David J. Adelstein, C.W. Fleming, E. Ilori, N.P. Joshi, Neil M. Woody, Jessica L. Geiger
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e367-e368
PURPOSE/OBJECTIVE(S) Patients with recurrent head and neck squamous cell carcinoma (HNSCC) who present with carotid encasement (CE) > 180˚, skin involvement and/or require bolus are not eligible for SBRT per RTOG 3507. The objective of this study wa
Publikováno v:
Current Treatment Options in Oncology. 22
Due to its relatively indolent disease course, the sensitivity of PSA testing, and the emergence of novel PET imaging, metastatic prostate cancer is particularly likely to present with a limited volume of disease. Patients with up to five metastatic
Autor:
Shlomo A. Koyfman, Deborah J. Chute, Robert R. Lorenz, C.W. Fleming, Lisa Rybicki, J. Ku, Brandon Prendes, Kevin J. Contrera, Zvonimir L. Milas, L. Schwartzman, Eric Lamarre, Neil M. Woody, Catherine H. Frenkel, David D. Xiong, Daniel Brickman, Daniel R. Carrizosa, John F. Greskovich, Jessica L. Geiger, David J. Adelstein, Nikhil P. Joshi, Brian B. Burkey, Joseph Scharpf, Matthew C. Ward
Publikováno v:
Oral oncology. 112
Objectives Patients with human papillomavirus (HPV) associated squamous cell carcinoma of the oropharynx (SCC-OP) have improved overall survival (OS) after distant metastasis (DM) compared to HPV negative patients. These patients may be appropriate c
Autor:
Nikhil P. Joshi, Jessica L. Geiger, Joanna Bodmann, Deborah J. Chute, C.W. Fleming, Neil M. Woody, Shlomo A. Koyfman, Denise I. Ives, J. Ferrini, Joycelin F. Canavan, Chandana A. Reddy, David J. Adelstein, B.A. Harr
Publikováno v:
Oral oncology. 103
This study examines the utility of surveillance imaging in detecting locoregional failures (LRF), distant failures (DF) and second primary tumors (SPT) in patients with human papillomavirus (HPV) associated oropharyngeal cancer (OPC) after definitive
Autor:
Robert R. Lorenz, E. Ilori, Shauna R. Campbell, Shlomo A. Koyfman, J. Ku, B. Matia, Chandana A. Reddy, Neil M. Woody, Eric Lamarre, N.P. Joshi, Brandon Prendes, Brian B. Burkey, Z S Mayo, C.W. Fleming, Joycelin F. Canavan, Joseph Scharpf
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e168
Purpose/objective(s) Hypofractionated intensity modulated radiation therapy (H-IMRT) is uncommonly used in head and neck cancers due to concern for toxicity. This study reviews our experience using H-IMRT for head and neck cancers and explores its to
Autor:
Eric Lamarre, John F. Greskovich, Shlomo A. Koyfman, D. Xiong, Jessica L. Geiger, C.W. Fleming, Brandon Prendes, Chengetai Mahomva, Brian B. Burkey, J. Ku, Wei Wei, Neil M. Woody, Nikhil P. Joshi, James R. Broughman, Kevin J. Contrera, Robert R. Lorenz, L. Schwartzman, Timothy D. Smile, David J. Adelstein, Joseph Scharpf
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e807-e808